A novel GIP-oxyntomodulin hybrid peptide acting through GIP, glucagon and GLP-1 receptors exhibits weight reducing and anti-diabetic properties. [electronic resource]
Producer: 20130716Description: 1655-62 p. digitalISSN:- 1873-2968
- Amino Acid Sequence
- Animals
- Blood Glucose -- analysis
- Cell Line
- Cricetinae
- Cyclic AMP -- biosynthesis
- Gastric Inhibitory Polypeptide -- chemistry
- Glucagon-Like Peptide-1 Receptor
- Hypoglycemic Agents -- pharmacology
- Insulin -- blood
- Male
- Mice
- Molecular Sequence Data
- Oxyntomodulin -- chemistry
- Peptides -- chemistry
- Receptors, Gastrointestinal Hormone -- metabolism
- Receptors, Glucagon -- metabolism
- Weight Loss -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.